HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teppei Okamoto Selected Research

Teppei Okamoto Research Topics

Disease

20Prostatic Neoplasms (Prostate Cancer)
01/2023 - 02/2013
10Neoplasms (Cancer)
03/2022 - 11/2012
7Carcinoma (Carcinomatosis)
01/2023 - 10/2021
7Frailty
10/2021 - 01/2020
5Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 01/2017
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 02/2013
2Erectile Dysfunction
10/2023 - 12/2019
2Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 02/2013
2Neoplasm Metastasis (Metastasis)
01/2022 - 11/2012
2Chronic Renal Insufficiency
10/2021 - 01/2012
2Disease Progression
05/2021 - 07/2020
2Overactive Urinary Bladder (Overactive Bladder)
01/2021 - 01/2020
2Diabetes Mellitus
01/2021 - 04/2020
2Malnutrition (Nutritional Deficiencies)
10/2018 - 09/2018
2Vascular Calcification
09/2018 - 01/2018
1Myocardial Infarction
10/2023
1Stroke (Strokes)
10/2023
1Body Weight (Weight, Body)
01/2023
1Inflammation (Inflammations)
11/2022
1Sleep Wake Disorders
03/2022
1Nocturia
03/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2022
1Wounds and Injuries (Trauma)
11/2021
1Anemia
05/2021
1Hypertension (High Blood Pressure)
01/2021
1Dyslipidemias (Dyslipidemia)
01/2021
1Pain (Aches)
07/2020
1Urolithiasis
04/2020
1Albuminuria
01/2020
1Urologic Neoplasms (Urological Cancer)
09/2019
1Atherosclerosis
09/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2018
1Hyperuricemia
01/2017
1Paraganglioma (Paragangliomas)
01/2014

Drug/Important Bio-Agent (IBA)

6Hormones (Hormone)IBA
01/2023 - 09/2019
6AndrogensIBA
01/2022 - 09/2019
4Hemoglobins (Hemoglobin)IBA
05/2021 - 01/2017
4Serum AlbuminIBA
04/2020 - 01/2018
3C-Reactive ProteinIBA
11/2022 - 01/2018
3Proton Pump InhibitorsIBA
03/2022 - 01/2018
3Cell-Free Nucleic AcidsIBA
11/2021 - 07/2020
2abirateroneIBA
01/2023 - 07/2020
2apalutamideIBA
01/2023 - 01/2022
2Abiraterone AcetateIBA
01/2023 - 05/2021
2Messenger RNA (mRNA)IBA
10/2022 - 02/2013
2PlatinumIBA
03/2022 - 12/2021
2Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 07/2020
2Immunoglobulin G (IgG)IBA
01/2022 - 02/2013
2Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2020
2Carboplatin (JM8)FDA LinkGeneric
10/2021 - 02/2013
2DNA (Deoxyribonucleic Acid)IBA
09/2021 - 07/2020
2ButyrylcholinesteraseIBA
10/2018 - 09/2018
2Glycoproteins (Glycoprotein)IBA
10/2018 - 02/2013
1omega-Chloroacetophenone (Mace)IBA
10/2023
1Docetaxel (Taxotere)FDA Link
01/2023
1AlbuminsIBA
11/2022
1SteroidsIBA
10/2022
1COVID-19 VaccinesIBA
10/2022
1Anti-Bacterial Agents (Antibiotics)IBA
03/2022
1Advanced Glycation End ProductsIBA
03/2022
1Immune Checkpoint InhibitorsIBA
03/2022
1Radium-233IBA
01/2022
1BNT162 VaccineIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1VaccinesIBA
01/2022
1Radium-223IBA
01/2022
1Androgen Receptors (Androgen Receptor)IBA
09/2021
1Adenosine Monophosphate (AMP)IBA
09/2021
1SaltsIBA
01/2021
1Serotonin (5 Hydroxytryptamine)IBA
01/2021
1B7-H1 AntigenIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Analgesics (Analgesic Drugs)IBA
07/2020
1enzalutamideIBA
07/2020
1Uric Acid (Urate)IBA
04/2020
1CreatinineIBA
01/2020
1Indicators and Reagents (Reagents)IBA
12/2019
1Oxidoreductases (Dehydrogenase)IBA
09/2019
1alpha-2-HS-GlycoproteinIBA
09/2018
1Phosphates (Orthophosphate)IBA
01/2018
1Parathyroid Hormone (Parathormone)IBA
01/2018
1Blood Group Antigens (Blood Groups)IBA
02/2013
1AntigensIBA
02/2013

Therapy/Procedure

13Therapeutics
01/2023 - 09/2019
8Castration
01/2023 - 01/2020
7Prostatectomy (Retropubic Prostatectomy)
01/2023 - 01/2020
4Drug Therapy (Chemotherapy)
03/2022 - 11/2012
4Cystectomy
03/2021 - 07/2019
4Radiotherapy
01/2021 - 11/2012
4Renal Dialysis (Hemodialysis)
09/2018 - 01/2011
3Immunotherapy
03/2022 - 03/2022
2Lymph Node Excision (Lymph Node Dissection)
01/2023 - 11/2022
1Kidney Transplantation
12/2023
1Drug Tapering
01/2023
1Nephroureterectomy
01/2023
1Neoadjuvant Therapy
10/2021
1Contraindications
01/2021
1Urinary Diversion (Ileal Conduit)
01/2020
1Blood Transfusion (Blood Transfusions)
01/2014